Cardiac troponin I increase after successful percutaneous coronary angioplasty: Predictors and long-term prognostic value

Angiology

Volumn 57, Issue 2, 2006, Pages 161-169

  Okmen, Ertan ^a,b   Cam, Nese ^a   Sanli, Arda ^a   Unal, Sennur ^a   Tartan, Zeynep ^a   Vural, Mutlu ^a  

^a DR SIYAMI ERSEK THORACIC AND CARDIOVASCULAR SURGERY TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOGEN RECEPTOR ANTAGONIST; TICLOPIDINE; TROPONIN I; BIOLOGICAL MARKER;

ACUTE HEART INFARCTION; ADULT; AGED; ARTERY DISSECTION; ARTICLE; BALLOON DILATATION; BLOOD SAMPLING; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY SPASM; CORONARY STENT; DEATH; DEMOGRAPHY; DIABETES MELLITUS; ENZYME ASSAY; FAMILY HISTORY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; HYPERTENSION; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; SMOKING; STABLE ANGINA PECTORIS; STATISTICAL ANALYSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS; ANGINA PECTORIS; BLOOD; COMPARATIVE STUDY; DISEASE COURSE; ENZYME IMMUNOASSAY; HEART MUSCLE; METABOLISM; MIDDLE AGED; TIME;

ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; MYOCARDIUM; PROGNOSIS; TIME FACTORS; TROPONIN I;

EID: 33645752097     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331970605700205     Document Type: Article

References (36)

1. Abdelmeguid A, Topol E, Whitlow P, et al: Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions. Circulation 94:1528-1536, 1996.
2. Ravkilde J, Nissen H, Mickley H, et al: Cardiac troponin T and CK-MB mass release after visually successful percutaneous transluminal coronary angioplasty in stable angina pectoris. Am Heart J 127:13-20, 1994.
3. Karim MA, Shinn M, Oskarsson H, et al: Significance of cardiac troponin T release after percutaneous transluminal coronary angioplasty. Am J Cardiol 76:521-523, 1995.
4. Abbas SA, Glazier J, WU AHB, et al: Factors associated with the release of cardiac troponin T following percutaneous transluminal coronary angioplasty. Clin Cardiol 19:782-786, 1996.
5. Garbaz E, Lung B, Lefevre G, et al: Frequency and prognostic value of cardiac troponin I elevation after coronary stenting. Am J Cardiol 84:515-518, 1999.
6. La Vecchia L, Bedogni F, Finocchi G, et al: Troponin T, troponin I and creatine kinase-MB mass after elective coronary stenting. Coron Artery Dis 7:535-540, 1996.
7. Cantor WJ, Newby LK, Christenson RH, et al, and The SYMPHONY and 2nd SYMPHONY Cardiac Markers Substudy Investigators: Prognostic significance of elevated troponin I after percutaneous coronary intervention. J Am Coll Cardiol 39:1738-1744, 2002.
8. Kong T, Davidson C, Meyers S, et al: Prognostic implication of creatine kinase elevation following elective coronary artery interventions. JAMA 277:461-466, 1997.
9. Adams JE, Bodor GS, Davila-Roman VG, et al: Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 88:101-106, 1993.
10. Bertinchant JP, Larue C, Pernel I, et al: Release kinetics of serum cardiac troponin I in ischemic myocardial injury. Clin Biochem 29:684-694, 1996.
11. Mair J, Genser N, Morandell D, et al: Cardiac troponin I in the diagnosis of myocardial injury and infarction. Clin Chim Acta 245:19-38, 1996.
12. Adams JE, Davila-Roman VG, Bessey PQ, et al: Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. N Engl J Med 330:670-674, 1994.
13. Hunt AC, Chow SL, Shiu MF, et al: Release of creatine kinase-MB and cardiac specific troponin-I following percutaneous transluminal coronary angioplasty. Eur Heart J 12:690-694, 1991.
14. Genser N, Mair J, Talazs H, et al: Cardiac troponin I to diagnose percutaneous transluminal coronary angioplasty-related myocardial injury. Clin Chem Acta 265:207-217, 1997.
15. Ryan TJ, Bauman WB, Kennedy JW, et al: Guidelines for percutaneous transluminal coronary angioplasty: A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). Circulation 78:486-502, 1988.
16. Smith SC Jr, Dove JT, Jacobs AK, et al: ACC/ AHA guidelines for percutaneous coronary intervention: A report of American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 37:2215-2239, 2001.
17. Abdelmeguid AE, Topol EJ: The myth of the myocardial " infarctlet" during percutaneous coronary revascularization procedures. Circulation 94:3369-3375, 1996.
18. Yadav J, Grube E, Rowold S, et al: Detection and characterization of emboli during coronary intervention (abstract). Circulation 100:I-780, 1999.
19. Harrington RA, Lincoff AM, Califf RM, et al: Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: Insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT). J Am Coll Cardiol 25:1693-1699, 1995.
20. Tardiff BE, Califf RM, Tcheng JE, et al, for the IMPACT-II Investigators: Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention. J Am Coll Cardiol 33:88-96, 1999.
21. Mehran R, Dangas G, Mintz GS, et al: Atherosclerotic plaque burden and CK-MB enzyme elevation after coronary interventions intravascular ultrasound study of 2,256 patients. Circulation 101:604-610, 2000.
22. Kugelmass AD, Cohen DJ, Moscucci M, et al: Elevation of the creatine kinase myocardial isoform following otherwise successful coronary atherectomy and stenting. Am J Cardiol 74:748-754, 1994.
23. Roberts WC, Kragel AH, Gertz SD, et al: Coronary arteries in unstable angina, acute myocardial infarction and sudden death. Am J Cardiol 127:1588-1593, 1994.
24. Shyu KG, Kuan PL, Cheng JJ, et al: Cardiac troponin T, creatine kinase, and isoform release after successful percutaneous transluminal coronary angioplasty with or without stenting. Am Heart J 135-862-867, 1998.
25. EPIC Investigators: Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 330:956-961, 1994.
26. Ellis SG, Lincoff AM, Miller D, et al, for the EPIC and EPILOG Investigators: Reduction in complications of angioplasty with abciximab occurs largely independently of baseline lesion morphology: Evaluation of 7E3 for the prevention of ischemic complications: Evaluation of PTCA to improve long-term outcome with abciximab GP IIb/IIIa receptor blockade. J Am Coll Cardiol 32:1619-1623, 1998.
27. EPILOG Investigators: Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 336:1689-1696, 1997.
28. CAPTURE Investigators: Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina. Lancet 349:1428-1435, 1997.
29. Briguori C, Sheiban I, De Gregorio J, et al: Direct coronary stenting without predilation. J Am Coll Cardiol 34:1910-1915, 1999.
30. Herz I, Assali A, Solodky A, et al: Effectiveness of coronary stent deployment without predilation. Am J Cardiol 84:89-91, 1999.
31. Oemrawsingh P, Schalij M, Srimahachota S, et al: Clinical and angiographic outcome of stent implantation without predilatation using the Jostent Flex Stent. J Invas Cardiol 12:187-193, 2000.
32. Commeau P, Huret B, Leclerq C, et al: Stealing without predilation with balloon in non-complex lesions: Immediate and mid-term results in a series of 106 consecutive implantations. Am J Cardiol 82:51S, 1998.
33. Attali P, Alleil B, Pettpas G, et al: Sensitivity and long-term prognostic value of cardiac troponin-I increase shortly after percutaneous transluminal coronary angioplasty. Clin Cardiol 21:353-356, 1998.
34. Bertinchant JP, Polge A, Lederman B, et al: Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris. Am J Cardiol 84:51-57, 1999.
35. Antman EM, Tanasijevic MJ, Thompson B, et al: Cardiac specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 335:1342-1349, 1996.
36. Hamm CW, Ravkilde J, Gerhardt W, et al: The prognostic value of serum troponin T in unstable angina. N Engl J Med 327:146-150, 1992.